7.45

5.64% -0.445

Lifeward Ltd (LFWD)

Overview News Price History Discussions Forecast

Lifeward Ltd stock is traded at $7.45, with a volume of 16,907. It is down -5.64% in the last 24 hours and down -6.87% over the past month. Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.

Previous Close:

$7.895

Open:

$7.99

24h Volume:

16,907

Relative Volume:

1.50

Market Cap:

$20.97M

Revenue:

$20.92M

Net Income/Loss:

$-25.87M

P/E Ratio:

-0.3785

EPS:

-19.6815

Net Cash Flow:

$-15.02M

1W Performance:

-3.06%

1M Performance:

-6.87%

6M Performance:

+21.64%

1Y Performance:

+1.44%

1-Day Range:

$7.1732

$7.99

1-Week Range:

$7.1732

$7.9999

52-Week Range:

$4.14

$10.56

Lifeward Ltd Stock (LFWD) Company Profile

Name

Lifeward Ltd

Sector

Healthcare (1080)

Industry

Medical Devices (141)

Phone

15082511154

Address

2 CABOT ROAD, HUDSON

Employee

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

LFWD's Discussions on Twitter

Compare LFWD vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LFWD Lifeward Ltd	7.45	21.81M	20.92M	-25.87M	-15.02M	-19.68
ABT Abbott Laboratories	111.25	191.92B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	339.21	133.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	91.27	116.18B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.83	74.52B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	91.60	53.63B	6.30B	1.07B	1.09B	1.8406

Lifeward Ltd Stock (LFWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-10-25	Initiated	Laidlaw	Buy
Apr-03-17	Downgrade	Barclays	Equal Weight → Underweight
Dec-16-16	Initiated	Oppenheimer	Outperform
Jul-15-16	Initiated	Piper Jaffray	Overweight
May-22-15	Upgrade	Canaccord Genuity	Hold → Buy
May-08-15	Reiterated	Barclays	Equal Weight
Oct-07-14	Initiated	Barclays	Equal Weight

View All

Lifeward Ltd Stock (LFWD) Latest News

Aug 14, 2026

Lifeward Ltd. Announces Resignation of Almog Adar from Chief Financial Officer, Effective September 30, 2026 - marketscreener.com

Aug 14, 2026

Lifeward Ltd. Announces Stepping Down of Board Members, Effective August 13, 2026 - marketscreener.com

Aug 14, 2026

Lifeward Q2 revenue beats estimates; adjusted EPS misses consensus - scanx.trade

Aug 14, 2026

Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Aug 14, 2026

Lifeward Ltd. 2026: Revenue $6.62M, Net income ($11.52M), EPS ($4.12) — 10-Q Summary - TradingView

Aug 14, 2026

Lifeward (NASDAQ: LFWD) doubles H1 loss and warns on going concern as it adds debt - Stock Titan

Aug 14, 2026

Lifeward Ltd Q2 revenue up 16% on higher ReWalk Personal exoskeleton sales - TradingView

Aug 14, 2026

Lifeward Revenue Rises 16% to $6.6 Million in Second Quarter 2026 - Quiver Quantitative

Aug 14, 2026

Lifeward’s CFO to Depart Sept. 30 as Three Directors Step Down - Stock Titan

Aug 14, 2026

Aug 13, 2026

Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside - Yahoo Finance

Aug 13, 2026

Aug 12, 2026

Lifeward Ltd expected to post a loss of $1.34 a shareEarnings Preview - TradingView

Aug 12, 2026

Aug 11, 2026

Lifeward Ltd. SEC Filing (Aug 11, 2026) - Stock Titan

Aug 11, 2026

Aug 10, 2026

Oramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - Stock Titan

Aug 10, 2026